Antengene Corporation, a Chinese clinical-stage biopharmaceutical company, has raised US$21 million in a series A financing round led by Qiming …
Visit ChinaMoneyNetwork.com for more daily finance news, including audio and video Internet podcasts covering important investment news and financial events in China. Follow us on Twitter @chinamoneypod subscribe to all episodes on iTunes.
China formally arrests Canadians in escalation of Huawei dispute
Apple will start iPhone 14 production in India at same time as China: Ming-Chi Kuo TECHTELEGRAPH
Chinese AI company 4Paradigm leads country’s machine learning market ahead of planned IPO
Tencent Makes Strategic Investment In UK’s Sensewhere
Taiwan Semiconductor Stock Was 6.67% Up Today
Lenovo’s Venture Arm Launches $500M Fund
Stocks stay positive on talk of US-China breakthrough
Investors begin buying again as emerging markets recover
Pelosi vows US support for Taiwan as officials warn of China military blockade
The Irrelevant Seven